Course Development Handbook
Appendix 7
s
Module specification template
Title
Code
Level
Credit rating
Pre-requisites
Type of module
Aims
Learning
outcomes/objectives
Content
Content (cont.)
Comments/notes
Renal Disease and Dysfunction
CLM01
7
20
Graduate Registered Pharmacists
The module is delivered within the workplace using the
module material provided by the London, Eastern and
South East Clinical Pharmacy Service.
1. To allow pharmacists to critically evaluate and apply
their pharmacological and pharmaceutical knowledge and
skills to the treatment of patients with renal disease and
dysfunction.
2. To provide pharmacists with a comprehensive
understanding of how the signs, symptoms and laboratory
investigations can aid in the monitoring of both disease
process and drug therapy.
3. To provide pharmacists with the knowledge and skills
required to provide pharmaceutical care for patients with
renal disease and dysfunction.
1. To evaluate clinical (signs and symptoms) and
laboratory test results in order to critique the drug
treatment of individuals presenting with renal
dysfunction,
2. To comprehensively understand the methods used to
assess renal function and to apply this to critically
evaluate the drug therapy of patients.
3. To fully describe the influence of renal impairment on
the pharmacokinetics of commonly administered drugs.
4. To demonstrate a comprehensive understanding of the
relevant pharmacological and pharmaceutical knowledge
in order to rationalise the management of patients with
acute or chronic renal impairment.
5. To critically evaluate the patient's response to
prescribed therapy in order to identify potential and
actual drug related problems,
6. To demonstrate competence in the provision of
pharmaceutical care to patients with renal disease or
dysfunction.
7. To demonstrate an ability to make sound judgements in
relation to the drug treatment of patients with renal
disease or dysfunction and to communicate this
effectively to other health care professions.
Anatomy, physiology and terminology associated with renal
function and disease.
Identification of markers associated with kidney function,
signs and symptoms associated with kidney disease;
classification of both acute and chronic renal disease.
Causes of renal disease and identification of risk factors
52
Course Development Handbook
Appendix 7
predisposing patients to renal dysfunction.
Teaching
strategies
and
Learning support
Influence of renal disease on the pharmacokinetics and
pharmacodynamics of drugs commonly administered to this
group of patients and strategies used for dose adjustment.
Methods used for the identification and prevention of drug
induced renal disorders. Management of the complications
associated with patients who present with either acute or
chronic renal disease. Renal replacement techniques used in
acute and chronic renal failure patients. Drug use in
patients receiving dialysis therapy. Drugs used in the
management
of
kidney
transplant
patients;
immunosuppressive and associated therapy.
learning Details of the standard module format are provided in the
programme specification. The material is presented in
electronic form and is normally provided to the student to
work through systematically under the supervision of an
appropriate senior clinical practitioner. Periodic meetings
with the local tutor allows understanding and the
application of this information to patient care to be
reviewed and the ability of the individual to perform key
skills to be evaluated.
Material is presented as a computer package to direct the
student learning. Students are then required to complete an
array of practice activities (see programme specification)
and demonstrate their competence to perform an array of
clinical tasks before being eligible to register for the module
assessment. Students are required to read and evaluate
articles contained within the appropriate medical journals in
addition to the appropriate chapters contained within the
general indicative texts listed below:
Kumar P, Clark M. Clinical Medicine(5th Edition)
Edinburgh. WB Sauders 2002.
Doods L. Drugs in Use. 3rd Edition. The Pharmaceutical
Press 2002.
Walker R, Edwards C. Clinical Pharmacy and Therapeutics.
3rd Edition. Churchill Livingstone. 2002.
The assessment strategy embraces the concept of “fitness
Assessment tasks
for purpose” so that students are required to demonstrate
their ability to apply the knowledge and skills acquired to
resolve a range of clinical problems. This requires the
student to gather and critically evaluate clinical data prior to
engaging in complex decision making, culminating in the
provision of advice to health care professionals and
patients. These problems are designed to reflect scenarios
routinely encountered in clinical practice. This requires
students to complete an objective structured clinical
examination (OSCE), comprising of 10 clinical scenarios,
reflecting clinical practice in the module being studied. To
pass the module students must satisfy the criteria in 7 of the
ten stations, and present an acceptable portfolio.
Brief description of module The module details the signs, symptoms and biochemical
content
and/or
aims tests associated with renal impairment and disease.
53
Course Development Handbook
Appendix 7
A comprehensive, evidence-based review of the available
treatment follows. Students are required to apply this
knowledge to resolve drug related problems in patients
housed in general medical wards and renal units.
Area examination board to Course Examination Board only (normally March and
September each year)
which module relates
Produced by practitioners specialising in renal medicine.
Module team/authors/
Module leader – Roger Fernandez, Senior Clinical
coordinator
Pharmacist, Mayday Hospital, Croydon.
Semester offered, where Not applicable.
appropriate
The School of Pharmacy and Biomolecular Sciences of the
Site where delivered
university is responsible for the designing and organising
the assessment process and the overall standard of the
course. The local hospitals have responsibility for the
tuition, which is co-ordinated by the London, Eastern and
South East Clinical Pharmacy Service.
August 1994
Date of first approval
September 2004
Date of last revision
Date of approval of this
version
3
Version number
Replacement for previous
module
Field for which module is
acceptable and status in that
field
Course(s) for which module PG Certificate in Applied Therapeutics. PG Diploma in
is acceptable and status in Clinical Pharmacy Practice.
that course
Pharmacy and Biomolecular Sciences
School home
Mr Jonathan Silcock. March 2004 - 2008
External examiner
(maximum 80 words)
54